Skip to content
Products
All
ELISpot Kits
ImmuneSelect Peptide Pools
Investor Relations
Products
All
ELISpot Kits
ImmuneSelect Peptide Pools
Investor Relations
EVALUATING T CELL DRIVEN IMMUNITY IN POST-VIRAL SYNDROMES
June 13 2024
Presentation by Dr. Nigel McCracken (COO)